|
PTP4A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43949999999549E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.50420000186469E-08 |
| Normal-vs-Stage2 |
2.611900E-04 |
| Normal-vs-Stage3 |
2.241700E-03 |
| Normal-vs-Stage4 |
6.444200E-01 |
| Stage1-vs-Stage2 |
6.064400E-01 |
| Stage1-vs-Stage3 |
7.353600E-02 |
| Stage1-vs-Stage4 |
1.137980E-01 |
| Stage2-vs-Stage3 |
3.093000E-01 |
| Stage2-vs-Stage4 |
1.779750E-01 |
| Stage3-vs-Stage4 |
3.498200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.51359999999957E-05 |
| Normal-vs-AfricanAmerican |
1.401360E-04 |
| Normal-vs-Asian |
7.250200E-02 |
| Caucasian-vs-AfricanAmerican |
8.391800E-01 |
| Caucasian-vs-Asian |
7.892400E-01 |
| AfricanAmerican-vs-Asian |
8.233400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27070000077723E-08 |
| Normal-vs-Female |
3.399600E-02 |
| Male-vs-Female |
5.398200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.036500E-02 |
| Normal-vs-Extreme_Weight |
3.43369999100673E-10 |
| Normal-vs-Obese |
2.215300E-03 |
| Normal-vs-Extreme_Obese |
6.002000E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.085600E-02 |
| Normal_Weight-vs-Obese |
6.834800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.257200E-01 |
| Extreme_Weight-vs-Obese |
4.291800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.981400E-01 |
| Obese-vs-Extreme_Obese |
1.989800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.330200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.3000999999967E-05 |
| Normal-vs-Age(61-80Yrs) |
1.87499999970697E-07 |
| Normal-vs-Age(81-100Yrs) |
1.213950E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.445170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.030100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.074200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.630440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.174600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.284600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.90499999611171E-08 |
| Normal-VS-Type2 PRCC |
4.554200E-04 |
| Normal-VS-KIRP CIMP |
2.075400E-01 |
| Normal-VS-Unclassified PRCC |
1.213740E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.100160E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.862200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.924800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.587600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.796200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.509700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.07969999996183E-06 |
| Normal-vs-N1 |
8.896200E-01 |
| Normal-vs-N2 |
9.011400E-01 |
| N0-vs-N1 |
3.110100E-02 |
| N0-vs-N2 |
3.706200E-01 |
| N1-vs-N2 |
9.576200E-01 |
|
|
